Urdu Version of the Dynamic Gait Index: Reliability and Validity Study

September 13, 2021 updated by: Riphah International University

Reliability and Validity of Urdu Version of the Dynamic Gait Index in Pakistani Geriatric Population

In this study, Investigators will observe the reliability and validity of dynamic gait index in Urdu language in Pakistani geriatric population with balance impairments.

Study Overview

Status

Completed

Conditions

Detailed Description

The aim of study is to translate and culturally adapt DGI into Urdu language and secondly to investigate the reliability and validity of DGI in geriatrics Pakistani population.This study will be cross sectional survey in which convenience sampling technique will be used to enroll participants as per pre-defined criteria.

The results of study will help to know the validity and reliability of DGI in Urdu version with balance impairments in geriatric population.The reliability of the scale will be checked through internal consistency and test-retest methods. Internal consistency will be analyzed with Cronbach's alpha value.Test-retest reliability will be assessed using an intraclass correlation coefficient with 60 patients

Study Type

Observational

Enrollment (Actual)

56

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Faisalabad, Punjab, Pakistan, 3800
        • Riphah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 80 years (Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly people, especially those of the advanced ages, suffer from coexistent disorders, many of which are chronically degenerative, falls and gait disorders are common issues. About one-third of all elderly people aged 65 as well as above fall at least once a year. Injury, physical impairments, morbidity, cognitive side effects, and even disability are all linked to fall because equilibrium and postural control are essential for the everyday work.

Description

Inclusion Criteria:

  • Age at least 65 years
  • Ability to walk a minimum of 6m with or without a walking Aid
  • One or more falls in the last year or
  • Observed balance impairment evaluated subjectively by a physical therapist during the initial training session (Time Up and Go test, Morse Fall Scale)

Exclusion Criteria:

  • Inability to understand or follow the instructions of the DGI
  • Experience with the DGI in the last 6 months
  • Acute illness or fracture in the lower extremities or knee/hip replacement within the last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Gait Index
Time Frame: 1st day
The Dynamic Gait Index tests the participant's ability to maintain balance while walking under different dynamic conditions and at the same time to react to different task requirements. An order scale with four points in the range from 0 to 3. "0" indicates the lowest functional level and "3" the highest functional level. The score of 19 predicts falls in the elderly and> 22 out of 24 in safe ambulances
1st day
Dynamic Gait Index
Time Frame: 2nd day
The Dynamic Gait Index tests the participant's ability to maintain balance while walking under different dynamic conditions and at the same time to react to different task requirements. An order scale with four points in the range from 0 to 3. "0" indicates the lowest functional level and "3" the highest functional level. The score of 19 predicts falls in the elderly and> 22 out of 24 in safe ambulances falls is the dynamic gait index.Each object is marked at a scale of 0 to 3, 3 with standard and 0 showing led to problems DGI's 24 is the highest result possible
2nd day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: 1st day
The Berg balance scale is an objective assessment of balance performance based on 14 items common to everyday activities. it is a 14-item scale that rates 0 (unable to perform) to 4 (normal performance) for each item. The total score is 56 points. Higher score higher balance ability.
1st day
Time Up and Go Test
Time Frame: 1st day
Time Up and Go Test is used determine fall risk and measure the progress of balance, sit to stand and walking, Cut of scores indicating risk of falls by Population Community Dwelling adults - 13.5 in seconds
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

August 20, 2021

Study Registration Dates

First Submitted

April 27, 2021

First Submitted That Met QC Criteria

April 27, 2021

First Posted (Actual)

April 30, 2021

Study Record Updates

Last Update Posted (Actual)

September 14, 2021

Last Update Submitted That Met QC Criteria

September 13, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • REC-FSD-00262

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Balance

3
Subscribe